Pittcon

Press Release

Dr. Schena to chair microarray symposium

Sunnyvale, CA, January 27, 2003 – On January 22nd the Coalesce Corporation, on behalf of the Pittsburgh Conference Committee, announced that it had chosen TeleChem’s Visiting Scholar Dr. Mark Schena to chair the inaugural Microarray Symposium at PITTCON 2003. The event will be held on March 9-14 at the Orange County Convention Center in Orlando Florida.

The Pittsburgh Conference or “PITTCON” was founded in 1950 to bring together researchers from basic and applied scientists to solve important scientific problems. Using science education as the underlying charter, PITTCON has grown into the world’s largest scientific conference in the United States. This year’s conference in Orlando will feature more than 1,100 vendors and 25,000 attendees. The Microarray Symposium will be the first event of its kind at PITTCON 2003.

“When the meeting organizers contacted me, I was fully booked”, said Dr. Schena. “But the size, scope and renown of the show were too exciting to pass up. It is a great privilege to be asked to Chair the inaugural Microarray Symposium at this year’s meeting.”

About TeleChem International, Inc.
TeleChem has diversified business activities organized into three corporate divisions: Life Sciences, Chemicals, and Diagnostics. The Life Sciences ArrayIt® Division provides a complete line of products and services for the microarray industry, a high-tech sector that uses tiny glass “chips” to explore the human genome. Microarray technology is speeding disease analysis, drug discovery, and crop plant development. The microarray products are sold under the ArrayIt® brand name, and include key patents (e.g. US 6,101,946) that protect the company’s core microarray manufacturing technology used in more than 10,000 corporate and university laboratories worldwide. The Chemicals Division provides import and export services and government contract work in the area of industrial chemicals including raw materials for plastics, water-soluble fertilizers, and cleaning compounds. The Chemicals Division enjoys expanding sales and profits, and provides financial support for research and development. The Diagnostics Division NGS-ArrayIt, Inc. has key patent filings in the areas of genotyping and medical diagnostics, and provides its tools and technologies to public health laboratories and other agencies involved in human disease analysis. NGS-ArrayIt plans to launch a new line of disease tests for sickle cell anemia, cystic fibrosis, hereditary hearing loss and other treatable diseases in the near future.

Media Contact
Paul Haje
Director of Public Relations
408-744-1331
Email: paul@ArrayIt®.com